Moderna Stock Jumps 4.5% as Major Cancer Vaccine Catalyst Approaches
Shares of vaccine maker Moderna ($MRNA) rose by about 4.5% in Thursday trading as investors looked ahead to an October 24 presentation of detailed ...
Merck & Co. Inc. (MRK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sivik Global Healthcare Krishen Sud | 40,000 | $5,812,400 | 3.32% | |
| 2. | Bailard Inc Thomas Bailard | 28,801 | $4,185,176 | +8% | 0.08% |
| 3. | Zevenbergen Capital Investments Nancy Zevenbergen | 1,565 | $227,410 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $88.25 | 2,833 | $249,999.98 | 2,933 | 2025-02-06 | Filing | |
| $88.50 | 15,000 | $1,327,500.00 | 16,000 | 2025-02-05 | Filing | |
| $113.68 | 3 | $341.04 | 20,599 | 2023-04-26 | Filing | |
| $105.47 | 136 | $14,343.92 | 20,631 | 2023-03-20 | Filing | |
| $109.20 | 11 | $1,201.20 | 20,495 | 2023-02-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $135.00 | 10,000 | $1,350,000.00 | 36,613 | 2026-08-13 | Filing | |
| $133.46 | 80,315 | $10,718,494.55 | 45,509 | 2026-08-12 | Filing | |
| $132.04 | 600 | $79,222.02 | 110,167 | 2026-08-12 | Filing | |
| $131.61 | 11,099 | $1,460,770.47 | 110,767 | 2026-08-12 | Filing | |
| $132.35 | 5,427 | $718,261.28 | 121,866 | 2026-08-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,778,501 | $232,233,983 | 0.35% | |
| 2. | 1,569,968 | $228,132,050 | 0.22% | |
| 3. | 1,090,990 | $158,531,757 | 0.82% | |
| 4. | 711,274 | $103,355,227 | 1.16% | |
| 5. | 708,878 | $103,007,062 | 0.54% |
News See All
Merck & Co., Inc. (MRK) Reports Promising Skin Cancer Trial Results for Keytruda and Personalized mRNA Vaccine
Baillie Gifford & Co, an independent investment management firm, released its third-quarter 2026 investor letter for “International Concentrated Growth Strategy”.
Merck (MRK) Reports a Negative Operating Margin and Pays Out 266% of Earnings. What Explains Both?
Merck & Co., Inc. (NYSE:MRK) closed at $145.45 on October 12.
3 ETFs With At Least 13% Upside Potential, According to the AI Analyst
TipRanks’ ETF AI Analyst sees at least 13% upside potential in iShares Core S&P Mid-Cap ETF ($IJH), Schwab US Dividend Equity ETF ($SCHD)...
Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why
Moderna shares ($MRNA) climbed by 13% to around $223 on Friday afternoon, pushing the U.S. biotech and pharma company past its one-year high of $21...
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
AI startup BioinvestGPT predicted the failure of Novartis AG’s ($NVS) experimental muscular dystrophy drug months before a disappointing Phase 3 re...
10 Best Bear Market Stocks to Invest In Right Now
U.S. consumer prices rose 3.4% in the year through August 2026, while the measure excluding food and energy increased 2.4%, according to the Bureau of Labor Statistics' September 11 release.
Eli Lilly (LLY) and AbbVie (ABBV) Are Expanding Their Pipelines. Their Valuations Tell Two Different Stories
Obesity drugs, pipeline investment, and manufacturing capacity are reshaping the pharmaceutical industry's growth equation.
Warner Bros. Is Set to Leave Nasdaq 100 and S&P 500 Indexes after $81 Billion Paramount Buyout
Warner Bros. Discovery ($WBD) is set to leave both the Nasdaq 100 and S&P 500 main indexes next week. The entertainment giant is finishing an $81 b...
3 ETFs to Buy with At Least 13% Upside Potential, According to the AI Analyst
TipRanks’ ETF AI Analyst sees at least 13% upside potential in Vanguard Growth ETF ($VUG), SPDR Portfolio S&P 500 Growth ETF ($SPYG), and iShares C...
Hedge Fund Resource Center